Skip to Content

What are the ingredient drugs in Ryzodeg 70/30?

Medically reviewed by Last updated on Apr 12, 2019.

Official Answer


Ryzodeg 70/30 (insulin degludec/insulin aspart) is formulated with a long-acting insulin analog degludec and a rapid-acting human insulin analog aspart combination, indicated to improve glycemic (blood sugar) control in adults with either type 1 or type 2 diabetes.

Ryzodeg 70/30 can be administered once or twice daily with any main meal.

The most common side effects with Ryzodeg 70/30 include hypoglycemia (low blood sugar), allergic reactions, injection site reactions, pitting at the injection site (lipodystrophy), itching, rash, edema (fluid build-up), and weight gain.

Ryzodeg 70/30 is manufactured by Novo Nordisk in Plainsboro, New Jersey.

Related Medical Questions

Drug Information

Related Support Groups